etelcalcetide

Ukraine

Drugs containing this active substance

  • PARSABIV

    The drug is intended for the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease undergoing hemodialysis.

    Form: solution for injection

    Active substance Dosage
    etelcalcetide 5 mg/ml

    ATC: H05BX04

    Manufacturer: Amgen Europe B.V. (labeling, secondary packaging, batch release)